DVYSR.ST - Devyser Diagnostics AB (publ)

Stockholm - Stockholm Real Time Price. Currency in SEK

Devyser Diagnostics AB (publ)

Instrumentvägen 19
Hägersten 126 53
46 8 56 21 58 50

IndustryDiagnostics & Research
Full Time Employees102

Key Executives

NameTitlePayExercisedYear Born
Mr. Fredrik AlpstenChief Exec. Officer4.16MN/A1966
Mr. Ulf KlangbyFounder & Deputy CEON/AN/A1969
Ms. Sabina BerlinChief Financial OfficerN/AN/A1983
Mr. Goran RydinChief Operating OfficerN/AN/A1969
Ms. Camilla WibergChief Human Resource OfficerN/AN/A1979
Mr. Theis KiplingChief Commercial OfficerN/AN/A1982
Mr. John MuradVP & GM of Devyser USN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.


Devyser Diagnostics AB (publ) provides diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia. The company offers products in the areas of post-transplantation, thalassemia, breast and ovarian cancer, non-invasive fetal RHD screening prenatal testing, hereditary, cystic fibrosis, cardiovascular, male infertility, and rapid aneuploidy analysis, as well as accessories. Its products are used for targeted cancer treatment to diagnosis genetic diseases and transplant patient follow-up. The company was incorporated in 2004 and is based in Hägersten, Sweden.

Corporate Governance

Devyser Diagnostics AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.